Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 14;12:730986. doi: 10.3389/fimmu.2021.730986

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Mtshali, San, Osman, Garrett, Balle, Giandhari, Onywera, Mngomezulu, Mzobe, de Oliveira, Rompalo, Mindel, Abdool Karim, Ravel, Passmore, Abdool Karim, Jaspan, Liebenberg and Ngcapu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Screening, enrolment and follow-up of the study participants in the CAPRISA 083 cohort study. Consenting women underwent bacterial vaginosis (BV) and Candida screening and point-of-care (POC) testing for sexually transmitted infections (STI): chlamydia (CT), gonorrhoea (NG) or Trichomoniasis (TV). Women diagnosed with Nugent-BV and any STI were treated, tested for cure at follow-up visits (6 and 12 weeks) and offered expedited partner therapy to deliver to their partners. Mucosal samples were collected at all visits. Women diagnosed with STIs only and/or who did not have vaginal microbiome data were excluded from the study and only those who attended all 3 visits and provided specimens were included.